Study of Ruxolitinib in Colorectal Cancer Patients

Clinical Trial ID NCT02119676

PubWeight™ 2.53‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02119676

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene 2015 1.03
2 Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. World J Gastroenterol 2016 0.78
3 Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy. Cancer Biol Ther 2015 0.76
Next 100